Neuranics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 11

Neuranics General Information

Description

Developer of advanced tunneling magnetoresistance (TMR) quantum sensors designed to enable ultra-sensitive, low-power biomagnetic detection for wearable and healthcare applications. The company offers proprietary sensor technology with high sensitivity and low energy consumption, allowing medical device manufacturers and consumer electronics developers to achieve enhanced precision in biomagnetic monitoring.

Contact Information

Website
www.neuranics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rothesay House
  • 134 Douglas Street
  • Glasgow G2 4HF
  • Scotland, United Kingdom
+44 0141
Primary Industry
Electronic Equipment and Instruments
Other Industries
Business/Productivity Software
Media and Information Services (B2B)
Vertical(s)
Nanotechnology, Big Data, Digital Health, Augmented Reality, Wearables & Quantified Self, Artificial Intelligence & Machine Learning, HealthTech, Virtual Reality
Corporate Office
  • Rothesay House
  • 134 Douglas Street
  • Glasgow G2 4HF
  • Scotland, United Kingdom
+44 0141

Neuranics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuranics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round Completed Generating Revenue
5. Seed Round 28-Mar-2025 Completed Generating Revenue
4. Grant 09-Oct-2024 Completed Generating Revenue
3. Seed Round 27-Sep-2023 Completed Generating Revenue
2. Accelerator/Incubator 30-May-2023 Completed Startup
1. University Spin-Out 01-Jan-2021 Completed Startup
To view Neuranics’s complete valuation and funding history, request access »

Neuranics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A Ordinary
A Ordinary
Ordinary Shares 983,797 $2.78 $2.78 1x $2.78 28.16%
To view Neuranics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Neuranics Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Neuranics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202510771-D0 Improvements in magnetoresistive sensing Pending 03-Jul-2025
GB-2703033-A Improvements in magnetoresistive sensing Pending 03-Jul-2025
GB-202506821-D0 System and method for biomagnetic data quality assessment Pending 05-May-2025
WO-2026233602-A1 System and method for biomagnetic data quality assessment Pending 05-May-2025
GB-202416479-D0 Magnetic flux concentrators Pending 08-Nov-2024 G01R33/0011
To view Neuranics’s complete patent history, request access »

Neuranics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuranics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Archangel Investors Angel Group Minority
Blackfinch Ventures Venture Capital Minority
The Quaternary Group Other Minority
Scottish Enterprise Growth/Expansion
Creator Fund Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Neuranics FAQs

  • When was Neuranics founded?

    Neuranics was founded in 2021.

  • Where is Neuranics headquartered?

    Neuranics is headquartered in Glasgow, United Kingdom.

  • What is the size of Neuranics?

    Neuranics has 25 total employees.

  • What industry is Neuranics in?

    Neuranics’s primary industry is Electronic Equipment and Instruments.

  • Is Neuranics a private or public company?

    Neuranics is a Private company.

  • What is Neuranics’s current revenue?

    The current revenue for Neuranics is .

  • How much funding has Neuranics raised over time?

    Neuranics has raised $10.7M.

  • Who are Neuranics’s investors?

    Archangel Investors, Blackfinch Ventures, The Quaternary Group, Scottish Enterprise, and Creator Fund are 5 of 11 investors who have invested in Neuranics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process